%0 Journal Article
%T Gemcitabine-induced supraventricular tachycardia: A rare manifestation
%A Linu Abraham
%A A Rudresha
%A Smitha Saldanha
%A Deepak Koppaka
%A Lakshmaiah Kuntegowdanahalli
%A Lokanatha Dasappa
%A Pretesh Kiran
%J Clinical Cancer Investigation Journal
%@ 2278-0513
%D 2016
%V 5
%N 2
%R 10.4103/2278-0513.178064
%P 200-202
%X Gemcitabine is a cytotoxic drug with superior toxicity profile and widely used in the management of various solid malignancies. The common side effects associated with gemcitabine are myelosuppression, diarrhea, and flu-like symptoms. Cardiac side effects due to gemcitabine are very rare. We present a case of an elderly female aged 69 years, diagnosed to have metastatic carcinoma gallbladder, and without any cardiac risk factors, who developed supraventricular tachycardia 3 days after gemcitabine infusion. We emphasize the need for careful and routine cardiac monitoring in an elderly patient who develops symptoms of tachyarrhythmia when on gemcitabine therapy.
%U https://ccij-online.org/article/gemcitabine-induced-supraventricular-tachycardia:-a-rare-manifestation-573